Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 3
2005 5
2006 4
2007 2
2008 5
2009 9
2010 10
2011 7
2012 1
2013 8
2014 3
2015 5
2016 6
2017 4
2018 3
2019 7
2020 5
2021 15
2022 5
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Mapping Mammary Tumor Traits in the Rat.
Flister MJ, Joshi A, Bergom C, Rui H. Flister MJ, et al. Among authors: rui h. Methods Mol Biol. 2019;2018:249-267. doi: 10.1007/978-1-4939-9581-3_12. Methods Mol Biol. 2019. PMID: 31228161 Free PMC article. Review.
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
Li Z, Jiao X, Robertson AG, Di Sante G, Ashton AW, DiRocco A, Wang M, Zhao J, Addya S, Wang C, McCue PA, South AP, Cordon-Cardo C, Liu R, Patel K, Hamid R, Parmar J, DuHadaway JB, Jones SJM, Casimiro MC, Schultz N, Kossenkov A, Phoon LY, Chen H, Lan L, Sun Y, Iczkowski KA, Rui H, Pestell RG. Li Z, et al. Among authors: rui h. Oncogene. 2023 Jun;42(22):1857-1873. doi: 10.1038/s41388-023-02668-9. Epub 2023 Apr 24. Oncogene. 2023. PMID: 37095257 Free PMC article.
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells.
McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, Lu Z, Zhang H, Li J, Pitarresi JR, Astsaturov I, Cukierman E, Rustgi AK, Stanger BZ, Rui H, Fuchs SY. McBrearty N, et al. Among authors: rui h. Mol Cancer Res. 2023 Mar 1;21(3):228-239. doi: 10.1158/1541-7786.MCR-22-0602. Mol Cancer Res. 2023. PMID: 36378658 Free PMC article.
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.
Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H. Chervoneva I, et al. Among authors: rui h. JCO Precis Oncol. 2023 Jan;7:e2100498. doi: 10.1200/PO.21.00498. JCO Precis Oncol. 2023. PMID: 36652667 Free PMC article.
Breast Cancer and Prolactin - New Mechanisms and Models.
Clevenger CV, Rui H. Clevenger CV, et al. Among authors: rui h. Endocrinology. 2022 Oct 1;163(10):bqac122. doi: 10.1210/endocr/bqac122. Endocrinology. 2022. PMID: 35922139 Free PMC article. Review.
Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer.
Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C. Kamaraju S, et al. Among authors: rui h. Endocrinology. 2021 Aug 1;162(8):bqab060. doi: 10.1210/endocr/bqab060. Endocrinology. 2021. PMID: 33735382 Review.
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
George J, Li Y, Kadamberi IP, Parashar D, Tsaih SW, Gupta P, Geethadevi A, Chen C, Ghosh C, Sun Y, Mittal S, Ramchandran R, Rui H, Lopez-Berestein G, Rodriguez-Aguayo C, Leone G, Rader JS, Sood AK, Dey M, Pradeep S, Chaluvally-Raghavan P. George J, et al. Among authors: rui h. Cell Rep. 2023 Mar 28;42(3):112228. doi: 10.1016/j.celrep.2023.112228. Epub 2023 Mar 7. Cell Rep. 2023. PMID: 36884347 Free PMC article. No abstract available.
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.
Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H. Chaudhary LN, et al. Among authors: rui h. Breast Cancer Res Treat. 2023 Oct;201(3):387-396. doi: 10.1007/s10549-023-07038-3. Epub 2023 Jul 17. Breast Cancer Res Treat. 2023. PMID: 37460683
125 results